Wholesalers worried Zuellig issues escalating to foreign drug companies.

Published: 2007-05-28 06:57:00

Updated: 2007-05-28 06:57:00

"The current wholesaler's margin issues of Zuellig" may not only give adverse impacts limitedly to Zuellig but also to other foreign drug corporations who were not associated with Zuellig and the wholesale distribution margins had not cut down. Accordingly Zuellig's rate-cutting policy should be ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK